Abstract 287P
Background
Yoga is one of the oldest therapies and has been practiced for millennia to promote physical and mental health. Yoga decreased cancer-related symptoms and treatment-related adverse effects, such as fatigue and nausea, and enhanced general well-being and quality of life. However, the duration of the yoga intervention in these investigations was a maximum of six months. In this study, the yoga intervention was given for one year.
Methods
The institutional ethics committee approved the study. This study enrolled a total of 96 patients after considering the inclusion and exclusion criteria, and they were randomly divided into two groups (non-yoga and yoga). Patients received training for the asanas Tadasna, Tiryaka Tadasana, Katichakrasana, Padadhirasana, Gomukhasana, Shavasana, Nadishodhan Pranayama, and Ujjayi Pranayama, which were performed for 45 minutes, five days per week, for the period of one year. We used the validated EORTC-QLQ30 and EORTC-BR23 questionnaires to assess the quality of life, symptomatic scale, fatigue, and functional scale in breast cancer patients. We calculated them at baseline, the fourth month, the eighth month, and the twelfth month, and compared them to the control group as well as with the intergroup.
Results
For each time point, 42 patients in the yoga group and 40 patients in the control group were analyzed. In the yoga group, two patients died and four were lost to follow-up and in non-yoga group, four patients died and four were lost to follow-up. At 4th(p<.05), 8th (p<0.01), and 12th month (p<0.001) post-baseline, the yoga group's quality of life improved significantly. In contrast, the non-yoga group shows substantial declines from baseline to the 4th(p<.05), 8th (p<0.01), and 12th month (p<0.001). The symptomatic and functional scales are also enhanced in the yoga group relative to the control group. The most significant difference from baseline was found in the functional scale at 12 months (p<0.05).
Conclusions
Long-term yoga intervention improved both their functional and symptomatic scales, as well as their quality of life. This suggests that yoga could be an effective complementary therapy for breast cancer patients undergoing treatment.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Ministry of Ayush, Government of India.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
303P - Long-term oncologic outcomes for patients undergoing volatile versus intravenous anesthesia for non-small cell lung cancer surgery
Presenter: Ji Hyung Hong
Session: Poster viewing 04
306P - Multimodal management and outcomes of stage III non-small cell lung cancer: KINDLE-Egypt analysis
Presenter: Rasha Aboelhassan
Session: Poster viewing 04
307P - Differential expression profiling of transcripts in stage IIIA non-small cell lung cancer (NSCLC) of smokers and non-smokers cases of north India: A geneto-environmental study
Presenter: Archana Mishra
Session: Poster viewing 04
308P - Phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small cell lung cancer in Japan (SAMURAI study)
Presenter: Masanao Nakashima
Session: Poster viewing 04
309P - Pneumonitis and corticosteroid treatment in patients with unresectable non-small cell lung cancer receiving durvalumab consolidation after definitive chemoradiotherapy
Presenter: Saori Murata
Session: Poster viewing 04
311P - Cost-effectiveness of alectinib compared with chemotherapy in first-line treatment for anaplastic lymphoma kinase-positive (ALK+) advanced non-small cell lung cancer in Thailand
Presenter: Sermsiri Sangroongruangsri
Session: Poster viewing 04
312P - ClinMatch: A clinical trial matching platform that improves trial accessibility among NSCLC patients through comprehensive genomic and clinical profiling
Presenter: Allen Chi Shing Yu
Session: Poster viewing 04
313P - A pool analysis of MET TKI SCC244 in NSCLC patients with MET overexpression
Presenter: Yongfeng Yu
Session: Poster viewing 04